MX382921B - Derivados aminofosfínicos para prevenir y tratar dolor ocular. - Google Patents

Derivados aminofosfínicos para prevenir y tratar dolor ocular.

Info

Publication number
MX382921B
MX382921B MX2018006580A MX2018006580A MX382921B MX 382921 B MX382921 B MX 382921B MX 2018006580 A MX2018006580 A MX 2018006580A MX 2018006580 A MX2018006580 A MX 2018006580A MX 382921 B MX382921 B MX 382921B
Authority
MX
Mexico
Prior art keywords
prevent
eye pain
treat eye
aminophosphine
derivatives
Prior art date
Application number
MX2018006580A
Other languages
English (en)
Spanish (es)
Other versions
MX2018006580A (es
Inventor
Goazigo Annabelle Reaux-Le
Michel Wurm
Hervé Poras
Parsadaniantz Stéphane Melik
Original Assignee
Pharmaleads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaleads filed Critical Pharmaleads
Publication of MX2018006580A publication Critical patent/MX2018006580A/es
Publication of MX382921B publication Critical patent/MX382921B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biochemistry (AREA)
MX2018006580A 2015-11-30 2016-11-30 Derivados aminofosfínicos para prevenir y tratar dolor ocular. MX382921B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1561598A FR3044227B1 (fr) 2015-11-30 2015-11-30 Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires
PCT/EP2016/079285 WO2017093322A1 (fr) 2015-11-30 2016-11-30 Dérivés aminophosphiniques pour la prévention et le traitement des douleurs oculaires

Publications (2)

Publication Number Publication Date
MX2018006580A MX2018006580A (es) 2018-08-01
MX382921B true MX382921B (es) 2025-03-13

Family

ID=55346018

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006580A MX382921B (es) 2015-11-30 2016-11-30 Derivados aminofosfínicos para prevenir y tratar dolor ocular.

Country Status (15)

Country Link
US (2) US20180344753A1 (enExample)
EP (1) EP3383403B1 (enExample)
JP (1) JP6889176B2 (enExample)
KR (1) KR102657652B1 (enExample)
CN (2) CN112121008A (enExample)
BR (1) BR112018010007A2 (enExample)
CA (1) CA3006365A1 (enExample)
DK (1) DK3383403T3 (enExample)
ES (1) ES2773148T3 (enExample)
FR (1) FR3044227B1 (enExample)
IL (1) IL259562B (enExample)
MX (1) MX382921B (enExample)
TW (1) TWI729039B (enExample)
WO (1) WO2017093322A1 (enExample)
ZA (1) ZA201804037B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
EP3592361B1 (fr) * 2017-03-09 2023-09-13 IACTA Pharmaceuticals, Inc. Dérivés aminophosphiniques pour la prévention et le traitement de l'inflammation oculaire
FR3063635B1 (fr) * 2017-03-09 2019-06-07 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire
FR3104581B1 (fr) * 2019-12-11 2021-11-26 Pharmaleads Procédé de préparation industrielle du sel disodique de ((2S)-3-([1,1'-biphenyl]-4-yl)-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl) methyl)propanoyl)-L-alanine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0987291A (ja) * 1995-09-26 1997-03-31 Wakamoto Pharmaceut Co Ltd 新規なアラニン誘導体
FR2755135B1 (fr) * 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
CA2275167C (en) * 1996-12-16 2008-10-28 Alcon Laboratories, Inc. The topical use of kappa opioid agonists to treat ocular pain
FR2777780B1 (fr) * 1998-04-22 2001-05-04 Inst Nat Sante Rech Med Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
FR2934267B1 (fr) * 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
FR2934627B1 (fr) 2008-07-29 2010-08-13 Paul Marie Bernard Dispositif de positionnement et de calage d'un garde corps escamotable sur plateforme support de banches
KR20150119082A (ko) * 2013-02-13 2015-10-23 노파르티스 아게 국소 안구 진통제

Also Published As

Publication number Publication date
WO2017093322A1 (fr) 2017-06-08
FR3044227B1 (fr) 2017-11-24
IL259562A (en) 2018-07-31
EP3383403B1 (fr) 2019-12-25
JP6889176B2 (ja) 2021-06-18
CA3006365A1 (fr) 2017-06-08
TWI729039B (zh) 2021-06-01
MX2018006580A (es) 2018-08-01
ES2773148T3 (es) 2020-07-09
CN108289901A (zh) 2018-07-17
KR20180095555A (ko) 2018-08-27
IL259562B (en) 2020-08-31
US20190167701A1 (en) 2019-06-06
BR112018010007A2 (pt) 2018-11-21
ZA201804037B (en) 2020-07-29
FR3044227A1 (fr) 2017-06-02
CN112121008A (zh) 2020-12-25
KR102657652B1 (ko) 2024-04-15
DK3383403T3 (da) 2020-03-16
JP2018536714A (ja) 2018-12-13
HK1259181A1 (zh) 2019-11-29
US20180344753A1 (en) 2018-12-06
TW201726146A (zh) 2017-08-01
EP3383403A1 (fr) 2018-10-10
US10688113B2 (en) 2020-06-23
CN108289901B (zh) 2021-05-04

Similar Documents

Publication Publication Date Title
MX2019004578A (es) Oxisteroles y metodos de uso de los mismos.
CL2018003701A1 (es) Compuestos heterocíclicos como inmunomoduladores.
MX2019003790A (es) Analogos de isoxazol como agonistas de fxr y metodos de uso de los mismos.
PH12018500040A1 (en) Indazole and azaindazole compounds as irak-4 inhibitors
UY35288A (es) Piridonamidas como moduladores de canales de sodio
MX2018000396A (es) Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4).
ECSP16005566A (es) Sulfonamidas como moduladores de canales de sodio
EA201891377A1 (ru) ПРИМЕНЕНИЕ МОДУЛЯТОРОВ КАНАЛОВ Kv3.1/Kv3.2/Kv3.3 ДЛЯ ЛЕЧЕНИЯ БОЛИ
MX2018006674A (es) Tratamiento de cancer usando 2-desoxi-2-fluoro-l-fucosa en combinacion con un inhibidor del punto de control.
MA40281B1 (fr) Composés de pyrazole et leur utilisation en tant qu' agents de blocage des canaux calciques de type t
MX391221B (es) Compuestos y composiciones y usos de los mismos.
MX390051B (es) Antagonistas de ep4.
MX388722B (es) Compuestos para tratar el cancer de ovario.
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
CL2016001756A1 (es) Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular.
CL2021001388A1 (es) Compuestos útiles en la terapia para el vih
MX378509B (es) Compuesto de pirimidina y su uso farmaceutico.
EA201692470A1 (ru) Фармацевтические комбинации
MX2021001612A (es) Compuestos utiles en terapia del vih.
ZA202002626B (en) Use of riluzole prodrugs to treat ataxias
MX385698B (es) Uso de un compuesto que comprende un grupo pirrolidinilo y pirimidinilo para tratar enfermedades oculares
JOP20190056B1 (ar) مركبات للاستخدام في علاج القصور الكلوي الحاد
MX388592B (es) Compuestos y metodos terapeuticos.
CR20160529A (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
PH12017501876A1 (en) Pyridopyrimidones and their use as nmda receptor modulators